The MIC3 Gene of Toxoplasma gondii Is a Novel Potent Vaccine Candidate against Toxoplasmosis, Infection and Immunity, vol.71, issue.11, pp.6222-6228, 2003. ,
DOI : 10.1128/IAI.71.11.6222-6228.2003
Vers des profils pharmacogénétiques? Les nouvelles frontières de la génomique Towards pharmacogenetic profiles? Surprising genomics, Biofutur Puteaux, issue.206, pp.86-88, 2000. ,
Replication-competent herpes simplex vectors: design and applications, Gene Therapy, vol.73, issue.SUP1, pp.170-177, 2005. ,
DOI : 10.1006/exer.1999.0711
Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI, and functional evaluation versus other antibody fragments, Toxicon, vol.43, issue.3, pp.233-241, 2004. ,
DOI : 10.1016/j.toxicon.2003.11.024
Living recombinant Saccharomyces cerevisiae secreting proteins or peptides as a new drug delivery system in the gut, Journal of Biotechnology, vol.110, issue.1, pp.37-49, 2004. ,
DOI : 10.1016/j.jbiotec.2004.01.012
The ???biodrug??? concept: an innovative approach to therapy, Trends in Biotechnology, vol.19, issue.10, pp.393-400, 2001. ,
DOI : 10.1016/S0167-7799(01)01739-5
Neutralising immunogenicity of a polyepitope antigen expressed in a transgenic food plant: a novel antigen to protect against measles, Vaccine, vol.21, issue.17-18, pp.17-18, 2003. ,
DOI : 10.1016/S0264-410X(02)00747-8
Vaccine That Induces T Cell Immunity against Region of Difference 1 Antigens, The Journal of Infectious Diseases, vol.190, issue.1, pp.115-122, 2004. ,
DOI : 10.1086/421468
Chemical Diversity of Polyene Macrolides Produced by Streptomyces noursei ATCC 11455 and Recombinant Strain ERD44 with Genetically Altered Polyketide Synthase NysC, Antimicrobial Agents and Chemotherapy, vol.48, issue.11, pp.48-4120, 2004. ,
DOI : 10.1128/AAC.48.11.4120-4129.2004
Engineered E. coli delivers therapeutic genes to the colonic mucosa, Gene Therapy, vol.12, issue.14, pp.1070-1078, 2005. ,
DOI : 10.1038/sj.gt.3302574
Differenciation neurale des cellules souches embryonnaires Neural differentiation of murine embryonic stem cells ES, MS Medecine sciences, vol.21, issue.5, pp.484-490, 2005. ,
Antibody engineering and its applications in tumor targeting and intracellular immunization, FEMS Microbiology Letters, vol.189, issue.1, pp.1-8, 2000. ,
DOI : 10.1111/j.1574-6968.2000.tb09197.x
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.615.5617
L'analyse pharmacoprotéomique: application de l'analyse protéomique à la découverte et au développement de nouvelles thérapeutiques: Du transcriptome au protéome, une nouvelle lecture de la cellule Pharmacoproteomics: application of proteomics for drug discovery and development: From transcriptome to proteome, a new lecture of the cell, Journal de la Societe de biologie, vol.196, issue.4, pp.317-322, 2002. ,
Monomolecular DNA Nanoparticles for Intravenous Delivery of Genes, Journal of the American Chemical Society, vol.127, issue.32, pp.11436-11441, 2005. ,
DOI : 10.1021/ja0522332
URL : https://hal.archives-ouvertes.fr/hal-00129832
Biomédicaments en France: Etat des lieux en 2004: Etude menée par les entreprises du médicament, 2004. ,
Comparative mycobacterial genomics as a tool for drug target and antigen discovery, European Respiratory Journal, vol.20, issue.Supplement 36, pp.78-86, 2002. ,
DOI : 10.1183/09031936.02.00400202
Effects of glucose limitation on biomass and spiramycin production by Streptomyces ambofaciens, Bioprocess and Biosystems Engineering, vol.65, issue.1, pp.55-61, 2005. ,
DOI : 10.1007/s00449-005-0015-2
Intracellular pH of Streptomyces pristinaespiralis is correlated to the sequential use of carbon sources during the pristinamycins-producing process, Enzyme and Microbial Technology, vol.34, issue.2, pp.101-107, 2004. ,
DOI : 10.1016/j.enzmictec.2003.06.002
Recombinant Environmental Libraries Provide Access to Microbial Diversity for Drug Discovery from Natural Products, Applied and Environmental Microbiology, vol.69, issue.1, pp.49-55, 2003. ,
DOI : 10.1128/AEM.69.1.49-55.2003
Breakthrough in chloroplast genetic engineering of agronomically important crops, Trends in Biotechnology, vol.23, issue.5, pp.238-245, 2005. ,
DOI : 10.1016/j.tibtech.2005.03.008
Entrapment of dispersed pancreatic islet cells in CultiSpher-S macroporous gelatin microcarriers: Preparation, in vitro characterization, and microencapsulation, Biotechnology and Bioengineering, vol.46, issue.6, pp.741-744, 2001. ,
DOI : 10.1002/bit.10053
Nonionic Amphiphilic Block Copolymers Promote Gene Transfer to the Lung, Human Gene Therapy, vol.16, issue.7, pp.821-829, 2005. ,
DOI : 10.1089/hum.2005.16.821
Interleukin 7-Engineered Stromal Cells: A New Approach for Hastening Naive T Cell Recruitment, Human Gene Therapy, vol.16, issue.6, pp.752-764, 2005. ,
DOI : 10.1089/hum.2005.16.752
Intelligent polymers as nonviral vectors, Gene Therapy, vol.96, issue.SUP1, pp.139-145, 2005. ,
DOI : 10.1016/S0304-4165(02)00202-7
Oral Treatment with Lactococcus lactis Expressing Staphylococcus hyicus Lipase Enhances Lipid Digestion in Pigs with Induced Pancreatic Insufficiency, Applied and Environmental Microbiology, vol.68, issue.6, pp.3166-3168, 2002. ,
DOI : 10.1128/AEM.68.6.3166-3168.2002
Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniques, Gene Therapy, vol.76, issue.SUP1, pp.62-72, 2005. ,
DOI : 10.1016/0042-6822(68)90122-0
Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation, Journal of Immunological Methods, vol.245, issue.1-2, pp.119-131, 2000. ,
DOI : 10.1016/S0022-1759(00)00274-X
Influence of Growth Conditions and Developmental Stage on N-Glycan Heterogeneity of Transgenic Immunoglobulin G and Endogenous Proteins in Tobacco Leaves, PLANT PHYSIOLOGY, vol.126, issue.3, pp.1314-1322, 2001. ,
DOI : 10.1104/pp.126.3.1314
Les anticorps appelés a la rescousse Le péril infectieux: quelles stratégies de lutte? Antibodies to the rescue, Biofutur Puteaux, vol.217, pp.78-81, 2001. ,
HSV-1-derived recombinant and amplicon vectors for preventive or therapeutic gene transfer: an overview, Gene Therapy, vol.12, issue.SUP1, p.153, 2005. ,
DOI : 10.1038/sj.gt.3302630
HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy, Current Gene Therapy, vol.5, issue.5, pp.445-458, 2005. ,
DOI : 10.2174/156652305774329285
NLS bioconjugates for targeting therapeutic genes to the nucleus, Advanced Drug Delivery Reviews, vol.55, issue.2, pp.295-306, 2003. ,
DOI : 10.1016/S0169-409X(02)00184-9
Recombinant Escherichia coli as a gene delivery vector into airway epithelial cells, Journal of Controlled Release, vol.97, issue.2, pp.371-381, 2004. ,
DOI : 10.1016/j.jconrel.2004.03.025
Liposome-based formulations for the delivery of oligonucleotides, STP pharma sciences, vol.11, issue.1, pp.31-44, 2001. ,
Cellules souches embryonnaires et thérapies cellulaires du système nerveux Embryonic stem cells and cell replacement therapies in the nervous system, MS Medecine sciences, vol.19, pp.6-7, 2003. ,
In vivo gene transfer to the rat retina using herpes simplex virus type 1 (HSV-1)-based amplicon vectors, Gene Therapy, vol.186, issue.16, pp.1283-1288, 2005. ,
DOI : 10.1038/sj.gt.3302553
Production de cellules germinales ?? partir de cellules souches embryonnaires de souris en culture, Gyn??cologie Obst??trique & Fertilit??, vol.33, issue.10, pp.813-818, 2005. ,
DOI : 10.1016/j.gyobfe.2005.07.039
URL : https://hal.archives-ouvertes.fr/hal-00129863
PEG shielded polymeric double-layered micelles for gene delivery, Journal of Controlled Release, vol.102, issue.3, pp.711-724, 2005. ,
DOI : 10.1016/j.jconrel.2004.11.005
Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors, Journal of Hepatology, vol.40, issue.2, pp.291-297, 2004. ,
DOI : 10.1016/j.jhep.2003.10.019
Stratégies de repeuplement du foie: Cellules souches et réparation tissulaire Liver repopulation strategies, Bulletin de l'Academie nationale de medecine, vol.189, issue.4, pp.625-633, 2005. ,
Les adénovirus réplicatifs conditionnels : un second souffle pour la thérapie génique du cancer Conditionally replicative adenoviruses: a second wind for cancer gene therapy, Bulletin du cancer, issue.12, pp.90-1039, 2003. ,
Production de kératinocytes autologues à buts thérapeutiques au sein d'un établissement pharmaceutique. Thérapie cellulaire Autologous keratinocyte production for cellular therapy within a pharmaceutical company. Cellular therapy, Journal de la Societe de biologie, vol.195, issue.1, pp.75-77, 2001. ,
DOI : 10.1051/jbio/2001195010075
Strategies post-genomique: Strategies contre le cancer Post-genomic strategies, Biofutur Puteaux, vol.245, pp.22-23, 2004. ,
Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domains, Gene Therapy, vol.12, issue.3, pp.211-224, 2005. ,
DOI : 10.1038/sj.gt.3302408
URL : https://hal.archives-ouvertes.fr/hal-00123930
Stable benefit of embryonic stem cell therapy in myocardial infarction, AJP: Heart and Circulatory Physiology, vol.287, issue.2, pp.471-479, 2004. ,
DOI : 10.1152/ajpheart.01247.2003
Cellules souches embryonnaires et clonage thérapeutique Embryonic stem cells and therapeutic cloning, MS Medecine sciences, vol.18, issue.2, pp.169-180, 2002. ,
DOI : 10.1051/medsci/2002182169
Les cellules-souches, un outil thérapeutique pour le futur? L'embryologie appliquée a la Neurochirurgie (I) Neurosurgical embryology. Part 4: What are stem-cells? Neurosurgical embryology (I), Neuro chirurgie Paris, vol.49, issue.4, pp.449-456, 2003. ,
Bacterial transfer of large functional genomic DNA into human cells, Gene Therapy, vol.28, issue.21, pp.1559-1572, 2005. ,
DOI : 10.1093/hmg/7.4.729
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity, Journal of General Virology, vol.86, issue.9, pp.2401-2410, 2005. ,
DOI : 10.1099/vir.0.81104-0
URL : https://hal.archives-ouvertes.fr/hal-00144427
Les vaccins du futur. Le péril infectieux: quelles stratégies de lutte? Vaccines of the future, Biofutur Puteaux, vol.217, pp.82-86, 2001. ,
NOUVEAUX PEPTIDES ANTIBIOTIQUES DE CHAMPIGNONS TRICHODERMA Biosynthèses dirigées Isolement, purification et caractérisation de la peptaibol-synthetase de T. longibrachiatum NEW PEPTIDE ANTIBIOTICS FROM TRICHODERMA FUNGI Directed biosynthesis Isolation, purification and characterisation of the peptaibol synthetase from T, 2000. ,
A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes, Vaccine, vol.23, issue.36, pp.4463-4472, 2005. ,
DOI : 10.1016/j.vaccine.2005.04.024
URL : https://hal.archives-ouvertes.fr/pasteur-00013659
A Single Injection of Recombinant Measles Virus Vaccines Expressing Human Immunodeficiency Virus (HIV) Type 1 Clade B Envelope Glycoproteins Induces Neutralizing Antibodies and Cellular Immune Responses to HIV, Journal of Virology, vol.78, issue.1, pp.146-157, 2004. ,
DOI : 10.1128/JVI.78.1.146-157.2004
Biology and application of alphaviruses in gene therapy, Gene Therapy, vol.9, issue.SUP1, pp.92-97, 2005. ,
DOI : 10.1016/j.jneumeth.2003.09.029
New tools for heterologous protein production in the yeast Yarrowia lipolytica. Recent research developments in microbiology, 2003. ,
Conceptions et naissances des médicaments : La vie du médicament Design and birth of drugs: The life of drugs, La Revue du praticien Paris, vol.52, issue.5, pp.482-485, 2002. ,
Cellules souches et clonage thérapeutique, des perspectives médicales en débat Stem cells and therapeutic cloning: medical perspectives under discussion, La Presse medicale, issue.5, pp.33-297, 1983. ,
DOI : 10.1016/s0755-4982(04)98568-5
The Design of Cationic Lipids for Gene Delivery, Current Pharmaceutical Design, vol.11, issue.3, pp.375-394, 2005. ,
DOI : 10.2174/1381612053382133
Embryonic stem cells pace the heart, Nature Biotechnology, vol.96, issue.10, pp.1237-1238, 2004. ,
DOI : 10.1152/ajpheart.01247.2003
A contained system for the field production of plant recombinant proteins. Molecular farming, pp.3-6, 2001. ,
Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice, Vaccine, vol.23, issue.36, pp.4489-4499, 2005. ,
DOI : 10.1016/j.vaccine.2005.04.025
Towards the development of edible vaccines for human papillomavirus in bananas. Molecular farming, pp.3-6, 2000. ,
Les adénovirus: de la structure à la vectorisation de gènes et à la vaccinologie. I: Virologie des adénovirus et des adénovirus recombinants Adenovirus: from structure to genes vectorisation and vaccinology, Virologie Montrouge, vol.7, issue.4, pp.267-279, 2003. ,
Downstream processing of viral vectors and vaccines, Gene Therapy, vol.72, issue.SUP1, pp.103-110, 2005. ,
DOI : 10.1073/pnas.0409141102
Robust functional gene validation by adenoviral vectors: one-step Escherichia coli-Derived Recombinant Adenoviral Genome construction, Gene Therapy, vol.11, issue.21, pp.1599-1605, 2004. ,
DOI : 10.1038/sj.gt.3302333
Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects, Gene Therapy, vol.8, issue.SUP1, pp.118-130, 2005. ,
DOI : 10.1002/jgm.511
Cellules souches et th??rapie cellulaire. Contribution au d??bat ??thique, Comptes Rendus Biologies, vol.325, issue.10, pp.1059-1063, 2002. ,
DOI : 10.1016/S1631-0691(02)01518-4
Protective Immunity Against ??-Cobratoxin Following a Single Administration of a Genetic Vaccine Encoding a Non-Toxic Cobratoxin Variant, Human Gene Therapy, vol.16, issue.3, pp.292-298, 2005. ,
DOI : 10.1089/hum.2005.16.292
Des cellules souches embryonnaires humaines pour le traitement de la maladie de Parkinson? Human embryonic stem cell in Parkinson's disease therapy?, MS Medecine sciences, vol.21, issue.1, pp.11-13, 2005. ,
Marrow Stromal Stem Cells for Repairing the Skeleton, Biotechnology and Genetic Engineering Reviews, vol.2, issue.1, pp.83-101, 2002. ,
DOI : 10.1080/02648725.2002.10648024
Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein, Cancer research Baltimore, vol.65, issue.2, pp.641-649, 2005. ,
Les vaccins a ADN DNA vaccines, Annales pharmaceutiques francaises, vol.61, issue.4, pp.219-233, 2003. ,
Combination of viral promoter sequences to generate highly active promoters for heterologous therapeutic protein over-expression in plants, Plant Science, vol.162, issue.5, pp.833-842, 2002. ,
DOI : 10.1016/S0168-9452(02)00031-6
Transient suppression of transgene expression by means of antisense oligonucleotides: a method for the production of toxin-transducing recombinant viruses, Gene Therapy, vol.9, issue.5, pp.358-362, 2002. ,
DOI : 10.1038/sj.gt.3301660
Biotechnologie du médicament: nouvelles stratégies en recherche pharmacologique Drug biotechnology: news strategies in pharmacologic research, Hepato gastro Montrouge, vol.9, issue.1, pp.19-24, 2002. ,
Production and Targeting of the Brucella abortus Antigen L7/L12 in Lactococcus lactis: a First Step towards Food-Grade Live Vaccines against Brucellosis, Applied and Environmental Microbiology, vol.68, issue.2, pp.910-916, 2002. ,
DOI : 10.1128/AEM.68.2.910-916.2002
URL : https://hal.archives-ouvertes.fr/hal-01128547
Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection, Gene Therapy, vol.11, issue.22, pp.1638-1647, 2004. ,
DOI : 10.1038/sj.gt.3302335
Conception and Realization of a Non-Cationic Non-Viral DNA Vector, Current Medicinal Chemistry, vol.11, issue.2, pp.169-177, 2004. ,
DOI : 10.2174/0929867043456133
LdARL-1 His-tagged recombinant protein: purification by immobilized metal affinity expanded bed adsorption, Journal of Chromatography B, vol.818, issue.1, pp.19-22, 2005. ,
DOI : 10.1016/j.jchromb.2004.10.022
URL : https://hal.archives-ouvertes.fr/hal-00069234
Production de cellules hématopoïétiques à partir des cellules ES. Thérapie cellulaire Production of hematopoietic cells from ES cells. Cellular therapy, Journal de la Societe de biologie, vol.195, issue.1, pp.13-18, 2001. ,
DOI : 10.1051/jbio/2001195010013
Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens, Highlights from the ECB11: Building Bridges between Biosciences and Bioengineering, pp.1-3, 2004. ,
DOI : 10.1016/j.jbiotec.2004.03.024
L'ingénierie des anticorps aujourd'hui: Obésite, anticorps, tumeurs: quelles avancées? Antibodies engineering, Biofutur Puteaux, vol.241, pp.22-25, 2004. ,
Artificial chromosomes for antibiotic-producing actinomycetes, Nature biotechnology, vol.18, issue.3, pp.343-345, 2000. ,
Une nouvelle arme contre le cancer: bilan sur les virus oncolytiques Insights into a new weapon against cancer: oncolytic viruses, Virologie Montrouge, vol.9, issue.4, pp.261-271, 2005. ,
Les thérapeutiques du futur en allergologie. Cytokines recombinantes, anticytokines, antagonistes des récepteurs de cytokines et inhibiteurs des molécules costimulatrices. Journées nationales de la Société française d'allergologie et d'immunologie clinique, pp.13-15, 2000. ,
Sécurité sanitaire des OGM utilisés en thérapeutique Health security -GMOs in therapeutics, Annales pharmaceutiques francaises, vol.61, issue.2, pp.103-108, 2003. ,
The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells, Cancer research Baltimore, issue.20, pp.61-7568, 2001. ,
Development of oral vaccine in plants against transmissible gastroenteritis virus of swine. Molecular farming, pp.3-6, 2000. ,
Utilisation thérapeutique des cellules souches. II. Les cellules souches adultes Therapeutic use of stem cells: II. Adult stem cells, La Revue du praticien Paris, vol.54, issue.14, pp.1515-1527, 2004. ,
Mise au point d'un système d'expression inductible dans les cellules Souches Embryonnaires An efficient system for conditionel gene expression in embryonnic stem cells, 2001. ,
Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors, Gene Therapy, vol.10, issue.23, pp.1982-1991, 2003. ,
DOI : 10.1038/sj.gt.3302103
Les cellules souches??: espoir de la th??rapie cellulaire, Pathologie Biologie, vol.51, issue.7, pp.432-433, 2003. ,
DOI : 10.1016/S0369-8114(03)00129-9
Recombinant human parvovirus B19 vectors, Pathologie Biologie, vol.50, issue.5, pp.295-306, 2002. ,
DOI : 10.1016/S0369-8114(02)00310-3
Targeted delivery of adenoviral vectors by cytotoxic T cells, Blood, vol.104, issue.8, pp.2272-2280, 2004. ,
DOI : 10.1182/blood-2003-11-3803
Nanoparticules d'ADN: Nanobiotechnologies: des avancees pour les sciences du vivant DNA nanoparticles, Biofutur Puteaux, vol.249, pp.46-49, 2004. ,